Nanoviricides (NNVC) Deferred Taxes (2011)
Nanoviricides (NNVC) posted Deferred Taxes of $35417.0 for Q1 2011.
Nanoviricides (NNVC) Deferred Taxes (2011) Analysis & Trends
Nanoviricides has reported Deferred Taxes for 1 years, with the latest figure at $35417.0 in Q1 2011.
- Quarterly Deferred Taxes changed N/A year-over-year to $35417.0 in Q1 2011, while the trailing twelve-month figure through Jun 2012 was $35417.0 (changed N/A YoY) and the FY2011 annual result came in at $22917.0, up 136.77% from the prior year.
- Deferred Taxes was little changed at $35417.0 in Q1 2011 per NNVC's latest filing.
- Over five years, Deferred Taxes peaked at $35417.0 in Q1 2011 and troughed at $35417.0 in Q1 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | - |
| 10 | Nanoviricides | 29.50 Mn | 26.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2011 | 35,417.00 |